PHENYLAMINO ISOTHIAZOLE CARBOXAMIDINES AS MEK INHIBITORS
申请人:Abdellaoui Hassan
公开号:US20080306063A1
公开(公告)日:2008-12-11
The invention concerns compounds which inhibit MEK and which have activity as anti-neoplastic agents. These compounds include N-substituted-3-hydroxy-5-arylamino-isothiazole-4-carboxamidines. Also included are the tautomeric isothiazol-3(2H)-ones.
[EN] PHENYLAMINO ISOTHIAZOLE CARBOXAMIDINES AS MEK INHIBITORS<br/>[FR] PHENYLAMINO ISOTHIAZOLE CARBOXAMIDINES COMME INHIBITEURS DE MEK
申请人:VALEANT PHARMACEUTICALS INT
公开号:WO2006133417A1
公开(公告)日:2006-12-14
[EN] The invention concerns compounds of formula (I) which inhibit MEK and which have activity as anti-neoplastic agents. These compounds include N-substituted- 3-hydroxy-5- arylamino-isothiazole-4-carboxamidines. Also included are the tautomeric isothiazol-3(2H)- ones. [FR] L'invention concerne des composés de formule (I) qui inhibent la MEK et qui ont une activité comme agents anti-néoplasiques. Ces composés comprennent des 3-hydroxy-5- arylamino-isothiazole-4-carboxamidines N-substituées. Ils comprennent aussi les tautomères des isothiazol-3(2H)- ones.
Phenylamino isothiazole carboxamidines as MEK inhibitors
申请人:Abdellaoui Hassan
公开号:US20060194802A1
公开(公告)日:2006-08-31
The invention concerns compounds which inhibit MEK and which have activity as anti-neoplastic agents. These compounds include N-substituted-3-hydroxy-5-arylamino-isothiazole-4-carboxamidines. Also included are the tautomeric isothiazol-3(2H)-ones.